Yahoo
OTC Markets OTCPK - Delayed Quote USD

ViaDerma, Inc. (VDRM)

0.0001 0.0000 (0.00%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for VDRM
  • Previous Close 0.0001
  • Open 0.0080
  • Bid 0.0066 x --
  • Ask 0.0084 x --
  • Day's Range 0.0005 - 0.0080
  • 52 Week Range 0.0001 - 0.0080
  • Volume 4,099
  • Avg. Volume 124,864
  • Market Cap (intraday) 123,371
  • Beta (5Y Monthly) 0.15
  • PE Ratio (TTM) --
  • EPS (TTM) 0.0000
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

ViaDerma, Inc., through its subsidiary, manufactures and sells pharmaceutical related products in the United States. The company's lead product is Vitastem, a tetracycline and topical delivery technology for antibiotics to pain relief, skincare, and other. It is also developing various products for vitiligo, psoriasis, eczema, and other skin conditions using SkinPass topical delivery system, as well as antifungal, cosmetics, and pain management products. In addition, company develops anti-aging skin care, pain management, hair-loss, and toenail fungus products. It also provides licenses for its technology for pharmaceutical industry in various therapeutic areas. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Las Vegas, Nevada.

viaderma.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

VDRM
50.00%
S&P 500 (^GSPC)
10.73%

1-Year Return

VDRM
0.00%
S&P 500 (^GSPC)
11.11%

3-Year Return

VDRM
99.14%
S&P 500 (^GSPC)
81.91%

5-Year Return

VDRM
99.30%
S&P 500 (^GSPC)
64.59%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -91.23%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    44.69k

  • Net Income Avi to Common (ttm)

    -1.52M

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.08k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    688.4k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: